(8 days)
The ArthroCare System is indicated for resection, ablation, and coagulation of soft tissue and hemostasis of blood vessels in arthroscopic and orthopedic procedures:
Arthroscopic and Orthopedic Procedures | Joint Specific or All Joints (ankle, elbow, hip, knee, shoulder, and wrist) |
---|---|
Ablation and Debridement | |
• ACL/PCL | Knee |
• Acromioplasty | Shoulder |
• Articular Cartilage | All Joints |
• Bursectomy | All Joints |
• Chondroplasty | All Joints |
• Facia | All Joints |
• Ligament | All Joints |
• Notchplasty | Knee |
• Scar Tissue | All Joints |
• Soft Tissue | All Joints |
• Subacromial Decompression | Shoulder |
• Synovectomy | All Joints |
• Tendon | All Joints |
Excision and Resection | |
• Acetabular Labrum | Hip |
• Articular Labrum | All Joints |
• Capsule | All Joints |
• Capsular Release | Knee |
• Cartilage Flaps | Knee |
• Cysts | All Joints |
• Discoid Meniscus | Knee |
• Frozen Shoulder Release | Shoulder |
• Glenoidale Labrum | Shoulder |
• Lateral Release | Knee |
• Ligament | All Joints |
• Loose Bodies | All Joints |
• Meniscal Cystectomy | Knee |
• Meniscectomy | Knee |
• Plica Removal | All Joints |
• Scar Tissue | All Joints |
• Soft Tissue | All Joints |
• Synovial Membrane | All Joints |
• Tendon | All Joints |
• Triangular Fibrocartilage (TFCC) | Wrist |
• Villusectomy | Knee |
Coagulation | |
• ACL/PCL | Knee |
• Articular Cartilage | All Joints |
• Carpal Ligaments | Wrist |
• Glenohumeral Capsule | Shoulder |
• Ligament | All Joints |
• Medial Retinaculum | Knee |
• Rotator Cuff | Shoulder |
• Tendon | All Joints |
• Wrist Tendons | Wrist |
The ArthroCare System is a bipolar, high frequency electrosurgical system consisting of three components: an electrosurgical generator called the Controller; a family of disposable, bipolar, single use Wands; and a reusable Patient Cable.
This document is a 510(k) summary for the ArthroCare System, an electrosurgical device. It details the device's intended use, its substantial equivalence to a predicate device, and confirms that modifications do not significantly affect safety or efficacy. However, the provided text does not contain any information about acceptance criteria or a study proving that the device meets specific acceptance criteria related to its performance metrics.
The document discusses:
- Device Description: A bipolar, high-frequency electrosurgical system comprising a Controller, disposable Wands, and a reusable Patient Cable.
- Intended Uses: Resection, ablation, and coagulation of soft tissue, and hemostasis of blood vessels in various arthroscopic and orthopedic procedures across multiple joints.
- Substantial Equivalence: The current submission (K032504) proposes modifications to performance specifications, dimensional specifications, and labeling of an already cleared device (K030551). It explicitly states that "The indications for use, technology, principle of operation, materials, packaging, and sterilization parameters of the ArthroCare System remain the same as in the predicate cleared 510(k)." The document concludes that the modifications are not substantial and do not significantly affect safety or efficacy.
Therefore, based on the provided text, I cannot extract the requested information regarding acceptance criteria and a study demonstrating the device meets those criteria. The document focuses on regulatory approval based on substantial equivalence, not on a detailed performance study with acceptance criteria.
§ 878.4400 Electrosurgical cutting and coagulation device and accessories.
(a)
Identification. An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.(b)
Classification. Class II.